# BK Technologies Corp: financial statements, quarterly

BKTI · NYSE · CIK 2186 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bkti.md) · [Financials](/companies/bkti/financials.md) · [Filings](/companies/bkti/filings.md) · [Insiders](/companies/bkti/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bkti/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.1](/filings/0001654954-23-013951.md) | [16.3 d](/filings/0001654954-24-003098.md) | [0.0](/filings/0001654954-24-005809.md) | [20.3](/filings/0001654954-24-010125.md) | [20.2](/filings/0001437749-25-033457.md) | [17.9 d](/filings/0001437749-26-007826.md) | [19.1](/filings/0001437749-26-016870.md) | [21.2](/filings/0001437749-26-027476.md) | [24.4](/filings/0001437749-25-033457.md) | [21.5 d](/filings/0001437749-26-007826.md) | [21.3](/filings/0001437749-26-016870.md) | [23.4](/filings/0001437749-26-027476.md) |
| Cost of revenue | $m | [13.7](/filings/0001437749-24-035026.md) | [10.6 d](/filings/0001437749-25-009464.md) | [11.9](/filings/0001437749-25-016253.md) | [12.7](/filings/0001437749-25-026668.md) | [12.3](/filings/0001437749-25-033457.md) | [10.5 d](/filings/0001437749-26-007826.md) | [10.1](/filings/0001437749-26-016870.md) | [11.1](/filings/0001437749-26-027476.md) | [12.2](/filings/0001437749-25-033457.md) | [10.7 d](/filings/0001437749-26-007826.md) | [10.3](/filings/0001437749-26-016870.md) | [11.3](/filings/0001437749-26-027476.md) |
| Gross profit | $m | not reported | not reported | not reported | [7.5](/filings/0001437749-25-026668.md) | [7.8](/filings/0001437749-25-033457.md) | [7.4 d](/filings/0001437749-26-007826.md) | [9.0](/filings/0001437749-26-016870.md) | [10.0](/filings/0001437749-26-027476.md) | [12.2](/filings/0001437749-25-033457.md) | [10.9 d](/filings/0001437749-26-007826.md) | [11.0](/filings/0001437749-26-016870.md) | [12.1](/filings/0001437749-26-027476.md) |
| Research and development | $m | not reported | not reported | not reported | [2.0](/filings/0001437749-25-026668.md) | [1.9](/filings/0001437749-25-033457.md) | [1.9 d](/filings/0001437749-26-007826.md) | [2.5](/filings/0001437749-26-016870.md) | [2.3](/filings/0001437749-26-027476.md) | [2.8](/filings/0001437749-25-033457.md) | [2.8 d](/filings/0001437749-26-007826.md) | [3.7](/filings/0001437749-26-016870.md) | [4.0](/filings/0001437749-26-027476.md) |
| Selling, general and administrative | $m | [5.8](/filings/0001437749-24-035026.md) | [5.3 d](/filings/0001437749-25-009464.md) | [5.3](/filings/0001437749-25-016253.md) | [5.5](/filings/0001437749-25-026668.md) | [5.2](/filings/0001437749-25-033457.md) | [5.2 d](/filings/0001437749-26-007826.md) | [6.0](/filings/0001437749-26-016870.md) | [6.0](/filings/0001437749-26-027476.md) | [7.3](/filings/0001437749-25-033457.md) | [6.6 d](/filings/0001437749-26-007826.md) | [7.7](/filings/0001437749-26-016870.md) | [8.3](/filings/0001437749-26-027476.md) |
| Operating income | $m | [0.6](/filings/0001437749-24-035026.md) | [0.4 d](/filings/0001437749-25-009464.md) | [1.0](/filings/0001437749-25-016253.md) | [2.0](/filings/0001437749-25-026668.md) | [2.6](/filings/0001437749-25-033457.md) | [2.2 d](/filings/0001437749-26-007826.md) | [2.9](/filings/0001437749-26-016870.md) | [4.0](/filings/0001437749-26-027476.md) | [4.8](/filings/0001437749-25-033457.md) | [4.2 d](/filings/0001437749-26-007826.md) | [3.3](/filings/0001437749-26-016870.md) | [3.8](/filings/0001437749-26-027476.md) |
| Interest expense | $m | [0.1](/filings/0001437749-24-035026.md) | [0.1 d](/filings/0001654954-24-003098.md) | [0.2](/filings/0001437749-25-016253.md) | [0.1](/filings/0001437749-25-026668.md) | [0.0](/filings/0001437749-25-033457.md) | [(0.0) d](/filings/0001437749-26-007826.md) | [(0.0)](/filings/0001437749-26-016870.md) | [(0.0)](/filings/0001437749-26-027476.md) | [(0.1)](/filings/0001437749-25-033457.md) | [(0.1) d](/filings/0001437749-26-007826.md) | [(0.2)](/filings/0001437749-26-016870.md) | [(0.2)](/filings/0001437749-26-027476.md) |
| Income tax | $m | [0.0](/filings/0001437749-24-035026.md) | [0.1 d](/filings/0001437749-25-009464.md) | [0.0](/filings/0001437749-25-016253.md) | [0.2](/filings/0001437749-25-026668.md) | [0.2](/filings/0001437749-25-033457.md) | [(1.5) d](/filings/0001437749-26-007826.md) | [0.7](/filings/0001437749-26-016870.md) | [0.3](/filings/0001437749-26-027476.md) | [1.5](/filings/0001437749-25-033457.md) | [0.2 d](/filings/0001437749-26-007826.md) | [0.7](/filings/0001437749-26-016870.md) | [0.8](/filings/0001437749-26-027476.md) |
| Net income | $m | [0.1](/filings/0001437749-24-035026.md) | [0.3 d](/filings/0001437749-25-009464.md) | [0.7](/filings/0001437749-25-033457.md) | [1.7](/filings/0001437749-25-033457.md) | [2.4](/filings/0001437749-25-033457.md) | [3.7 d](/filings/0001437749-26-007826.md) | [2.1](/filings/0001437749-26-027476.md) | [3.7](/filings/0001437749-26-027476.md) | [3.4](/filings/0001437749-25-033457.md) | [4.2 d](/filings/0001437749-26-007826.md) | [2.8](/filings/0001437749-26-027476.md) | [3.2](/filings/0001437749-26-027476.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001437749-24-035026.md) | not reported | [0.19](/filings/0001437749-25-016253.md) | [0.47](/filings/0001437749-25-026668.md) | [0.63](/filings/0001437749-25-033457.md) | not reported | [0.55](/filings/0001437749-26-016870.md) | [0.96](/filings/0001437749-26-027476.md) | [0.87](/filings/0001437749-25-033457.md) | not reported | [0.69](/filings/0001437749-26-016870.md) | [0.79](/filings/0001437749-26-027476.md) |
| Basic EPS | $ per share | [0.03](/filings/0001437749-24-035026.md) | not reported | [0.19](/filings/0001437749-25-016253.md) | [0.47](/filings/0001437749-25-026668.md) | [0.67](/filings/0001437749-25-033457.md) | not reported | [0.60](/filings/0001437749-26-016870.md) | [1.03](/filings/0001437749-26-027476.md) | [0.93](/filings/0001437749-25-033457.md) | not reported | [0.74](/filings/0001437749-26-016870.md) | [0.84](/filings/0001437749-26-027476.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.1](/filings/0001654954-23-013951.md) | [3.5](/filings/0001437749-25-009464.md) | [0.0](/filings/0001654954-24-005809.md) | [3.0](/filings/0001654954-24-010125.md) | [4.2](/filings/0001437749-24-035026.md) | [7.1](/filings/0001437749-26-007826.md) | [8.9](/filings/0001437749-25-016253.md) | [11.9](/filings/0001437749-25-026668.md) | [21.5](/filings/0001437749-25-033457.md) | [22.8](/filings/0001437749-26-027476.md) | [29.0](/filings/0001437749-26-016870.md) | [29.9](/filings/0001437749-26-027476.md) |
| Current assets | $m | [36.7](/filings/0001654954-23-013951.md) | [37.2](/filings/0001437749-25-009464.md) | [0.0](/filings/0001654954-24-005809.md) | [37.6](/filings/0001654954-24-010125.md) | [34.9](/filings/0001437749-24-035026.md) | [36.9](/filings/0001437749-26-007826.md) | [39.8](/filings/0001437749-25-016253.md) | [44.8](/filings/0001437749-25-026668.md) | [51.7](/filings/0001437749-25-033457.md) | [49.0](/filings/0001437749-26-027476.md) | [54.6](/filings/0001437749-26-016870.md) | [60.5](/filings/0001437749-26-027476.md) |
| Total assets | $m | [49.1](/filings/0001654954-23-013951.md) | [49.4](/filings/0001437749-25-009464.md) | [0.1](/filings/0001654954-24-005809.md) | [48.9](/filings/0001654954-24-010125.md) | [46.4](/filings/0001437749-24-035026.md) | [51.5](/filings/0001437749-26-007826.md) | [56.1](/filings/0001437749-25-016253.md) | [60.4](/filings/0001437749-25-026668.md) | [66.9](/filings/0001437749-25-033457.md) | [63.8](/filings/0001437749-26-027476.md) | [68.8](/filings/0001437749-26-016870.md) | [73.7](/filings/0001437749-26-027476.md) |
| Current liabilities | $m | [22.9](/filings/0001654954-23-013951.md) | [20.4](/filings/0001437749-25-009464.md) | [0.0](/filings/0001654954-24-005809.md) | [17.3](/filings/0001654954-24-010125.md) | [12.2](/filings/0001437749-24-035026.md) | [14.0](/filings/0001437749-26-007826.md) | [15.2](/filings/0001437749-25-016253.md) | [15.9](/filings/0001437749-25-026668.md) | [17.9](/filings/0001437749-25-033457.md) | [11.6](/filings/0001437749-26-027476.md) | [13.3](/filings/0001437749-26-016870.md) | [14.4](/filings/0001437749-26-027476.md) |
| Total liabilities | $m | [30.5](/filings/0001654954-23-013951.md) | [28.1](/filings/0001437749-25-009464.md) | [0.0](/filings/0001654954-24-005809.md) | [25.5](/filings/0001654954-24-010125.md) | [20.4](/filings/0001437749-24-035026.md) | [21.7](/filings/0001437749-26-007826.md) | [23.7](/filings/0001437749-25-016253.md) | [23.7](/filings/0001437749-25-026668.md) | [25.9](/filings/0001437749-25-033457.md) | [19.1](/filings/0001437749-26-027476.md) | [21.1](/filings/0001437749-26-016870.md) | [21.7](/filings/0001437749-26-027476.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [18.6](/filings/0001437749-24-035026.md) | [21.3](/filings/0001437749-26-007826.md) | [21.5](/filings/0001437749-25-033457.md) | [23.4](/filings/0001437749-25-033457.md) | [26.0](/filings/0001437749-25-033457.md) | [29.8](/filings/0001437749-26-027476.md) | [32.4](/filings/0001437749-26-027476.md) | [36.8](/filings/0001437749-26-027476.md) | [41.0](/filings/0001437749-25-033457.md) | [44.7](/filings/0001437749-26-027476.md) | [47.7](/filings/0001437749-26-027476.md) | [52.0](/filings/0001437749-26-027476.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.4 d](/filings/0001437749-24-035026.md) | [(2.3) d](/filings/0001437749-25-009464.md) | [(0.8)](/filings/0001437749-25-016253.md) | [4.1 d](/filings/0001437749-25-026668.md) | [5.7 d](/filings/0001437749-25-033457.md) | [3.8 d](/filings/0001437749-26-007826.md) | [2.5](/filings/0001437749-26-016870.md) | [3.5 d](/filings/0001437749-26-027476.md) | [10.4 d](/filings/0001437749-25-033457.md) | [3.0 d](/filings/0001437749-26-007826.md) | [6.8](/filings/0001437749-26-016870.md) | [0.6 d](/filings/0001437749-26-027476.md) |
| Capital expenditure | $m | [0.9 d](/filings/0001437749-24-035026.md) | [0.3 d](/filings/0001437749-25-009464.md) | [0.2](/filings/0001437749-25-016253.md) | [0.2 d](/filings/0001437749-25-026668.md) | [0.5 d](/filings/0001437749-25-033457.md) | [0.4 d](/filings/0001437749-26-007826.md) | [0.3](/filings/0001437749-26-016870.md) | [0.3 d](/filings/0001437749-26-027476.md) | [0.4 d](/filings/0001437749-25-033457.md) | [0.2 d](/filings/0001437749-26-007826.md) | [0.5](/filings/0001437749-26-016870.md) | [0.3 d](/filings/0001437749-26-027476.md) |
| Dividends paid | $m | [0.0 d](/filings/0001654954-23-013951.md) | [0.0 d](/filings/0001654954-24-003098.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-016870.md) | [0.0 d](/filings/0001437749-26-027476.md) | not reported | not reported | [0.2](/filings/0001437749-26-016870.md) | [(0.1) d](/filings/0001437749-26-027476.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2021 (2021-09-30) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.8](/filings/0001654954-22-014750.md) | [16.9](/filings/0001654954-22-011002.md) | [17.0](/filings/0001654954-22-014750.md) | [3.4](/filings/0001437749-24-035026.md) | [3.6](/filings/0001437749-25-016253.md) | [3.6](/filings/0001437749-25-026668.md) | [3.8](/filings/0001437749-25-033457.md) | [3.9](/filings/0001437749-26-016870.md) | [3.9](/filings/0001437749-26-027476.md) | [4.0](/filings/0001437749-25-033457.md) | [4.0](/filings/0001437749-26-016870.md) | [4.0](/filings/0001437749-26-027476.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,769,389 at 2026-08-06, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027476.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.